Reuters logo
BRIEF-Anges MG receives IND approval from FDA
April 25, 2017 / 3:16 AM / 5 months ago

BRIEF-Anges MG receives IND approval from FDA

April 25 (Reuters) - Anges MG Inc

* Says it received investigational new drug (IND) approval from FDA, for a clinical trial with F-kappaB decoy oligo DNA in U.S, for treatment of discogenic lower back pain

Source text in Japanese:goo.gl/qccLX9

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below